论文信息 - Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysis. - 字舞流文

Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysis.

M. Mohty | P. Moreau | X. Leleu | T. Facon | C. Min | L. Karlin | T. Martin | C. Tekle | M. Risse | R. Baker | Sandrine Schwab | Nicole M. Armstrong